FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Norman Coleman

Research Profile

Chemicals & Drugs

Disorders

Procedures

Concepts & Ideas

Activities & Behaviors

Nuclear Weapons

Co-author Network

Publications

TOP 3
Steven H Lin; Bo Lu; Minesh Mehta; David Peereboom; Jann Sarkaria; Jinsil Seong; Bhadrasain Vikram; Dian Wang; Meng X Welliver; Stephen Yoo; Edgar Ben-Josef; Jeffrey Bradley; Kevin S Choe; Christine H Chung; C Norman Coleman; Martin J Edelman; Thomas J George; Chandan Guha; Sunil Krishnan; Theodore S Lawrence; Quynh-Thu Le
Opportunities and challenges in the era of molecularly targeted agents and radiation therapy.
Yaacov Richard Lawrence; Mitchell Machtay; Paul Okunieff; Naoko Takebe; Bhadrasain Vikram; Soren M Bentzen; Arnab Chakravarti; C Norman Coleman; Walter J Curran; James J Dignam; Boris Freidlin; Adam P Dicker
NCI-RTOG translational program strategic guidelines for the early-stage development of radiosensitizers.
C Norman Coleman
Fukushima and the future of radiation research.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Norman Coleman (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Steven H Lin; Bo Lu; Minesh Mehta; David Peereboom; Jann Sarkaria; Jinsil Seong; Bhadrasain Vikram; Dian Wang; Meng X Welliver; Stephen Yoo; Edgar Ben-Josef; Jeffrey Bradley; Kevin S Choe; Christine H Chung; C Norman Coleman; Martin J Edelman; Thomas J George; Chandan Guha; Sunil Krishnan; Theodore S Lawrence; Quynh-Thu Le
Opportunities and challenges in the era of molecularly targeted agents and radiation therapy.
Journal of the National Cancer Institute 2013;105(10):686-93.
2013: Yaacov Richard Lawrence; Mitchell Machtay; Paul Okunieff; Naoko Takebe; Bhadrasain Vikram; Soren M Bentzen; Arnab Chakravarti; C Norman Coleman; Walter J Curran; James J Dignam; Boris Freidlin; Adam P Dicker
NCI-RTOG translational program strategic guidelines for the early-stage development of radiosensitizers.
Journal of the National Cancer Institute 2013;105(1):11-24.
2013: C Norman Coleman
Fukushima and the future of radiation research.
Radiation research 2013;179(1):1-8.
2013: Adeola Y Makinde; Sanjeewani T Palayoor; David Cerna; Molykutty John-Aryankalayil; C Norman Coleman
Radiation survivors: understanding and exploiting the phenotype following fractionated radiation therapy.
Molecular cancer research : MCR 2013;11(1):5-12.
2012: C Norman Coleman; Richard Hatchett; Chad Hrdina; Ann R Knebel; Monique K Mansoura; Scott Nystrom; Katherine S Wallace; J Jaime Caro; Rocco Casagrande; Kenneth D Cliffer; Steven A Adams
User-managed inventory: an approach to forward-deployment of urgently needed medical countermeasures for mass-casualty and terrorism incidents.
Disaster medicine and public health preparedness 2012;6(4):408-14.
2012: R R Love; O M Ginsburg; C Norman Coleman
Public health oncology: a framework for progress in low- and middle-income countries.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012;23(12):3040-5.
2012: Molykutty John-Aryankalayil; Scott R Magnuson; Adeola Y Makinde; Sanjeewani T Palayoor; Charles B Simone; David Cerna; Michael T Falduto; C Norman Coleman
Fractionated radiation alters oncomir and tumor suppressor miRNAs in human prostate cancer cells.
Radiation research 2012;178(3):105-17.
2012: David Close; Mike Sevilla; C Norman Coleman
William A. Bernhard (1942-2012).
Radiation research 2012;178(1):101-3.
2012: Justin E Bekelman; Soren M Bentzen; Deborah Watkins-Bruner; C Norman Coleman; Walter J. CURRAN; James A Deye; James Dignam; Jason A Efstathiou; T J FitzGerald; Coen W Hurkmans; Geoffrey S Ibbott; J Jack Lee; Thomas E Merchant; Jeff Michalski; Jatinder R Palta; Richard Simon; Randal K Ten Haken; Robert Timmerman; Sean R. Tunis; Bhadrasain Vikram; James A Purdy
Redesigning radiotherapy quality assurance: opportunities to develop an efficient, evidence-based system to support clinical trials--report of the National Cancer Institute Work Group on Radiotherapy Quality Assurance.
International journal of radiation oncology, biology, physics 2012;83(3):782-90.
2012: David Cerna; C Norman Coleman; Siobhan Flaherty; Hongyun Li; Naoko Takebe; Stephen S Yoo
Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) activity by small molecule GMX1778 regulates reactive oxygen species (ROS)-mediated cytotoxicity in a p53- and nicotinic acid phosphoribosyltransferase1 (NAPRT1)-dependent manner.
The Journal of biological chemistry 2012;287(26):22408-17.
2012: Sanjeewani T Palayoor; David Cerna; Michael T Falduto; Molykutty J-Aryankalayil; Scott R Magnuson; Adeola Y Makinde; C Norman Coleman
Gene expression profile of coronary artery cells treated with nonsteroidal anti-inflammatory drugs reveals off-target effects.
Journal of cardiovascular pharmacology 2012;59(6):487-99.
2012: C Norman Coleman; Nicole Lurie
Emergency medical preparedness for radiological/nuclear incidents in the United States.
Journal of radiological protection : official journal of the Society for Radiological Protection 2012;32(1):N27-32.
2012: C Norman Coleman; Robert C Whitcomb; Charles W Miller; Michael A Noska
Commentary on the combined disaster in Japan.
Radiation research 2012;177(1):15-7.
2011: Jerry W Shay; Frank M Sulzman; C Norman Coleman; Francis A Cucinotta; John D Minna
From mice and men to earth and space: joint NASA-NCI workshop on lung cancer risk resulting from space and terrestrial radiation.
Cancer research 2011;71(22):6926-9.
2011: Julie L Ryan; Bhadrasain Vikram; C Norman Coleman; Sunil Krishnan; Benjamin Movsas; Stephen S Yoo
Decreasing the adverse effects of cancer therapy: an NCI Workshop on the preclinical development of radiation injury mitigators/protectors.
Radiation research 2011;176(5):688-91.
2011: Nicholas Dainiak; Arnold Ganser; Robert Nicolas Gent; Claude Gorin; Martin Hauer-Jensen; L Andrew Huff; Patricia Lillis-Hearne; Kazuhiko Maekawa; Jeffrey Nemhauser; Ray Powles; Rita Schneider; Holger Schünemann; Alla Shapiro; Leif Stenke; Nelson Valverde; David Weinstock; Douglas White; Joseph Albanese; Judith Bader; Elena Buglova; Zhanat Carr; Nelson Chao; C Norman Coleman; Viktor Meineke
First global consensus for evidence-based management of the hematopoietic syndrome resulting from exposure to ionizing radiation.
Disaster medicine and public health preparedness 2011;5(3):202-12.
2011: Nicholas Dainiak; Arnold Ganser; Robert Nicolas Gent; Claude Gorin; Martin Hauer-Jensen; L Andrew Huff; Patricia Lillis-Hearne; Kazuhiko Maekawa; Jeffrey Nemhauser; Ray Powles; Rita Schneider; Holger Schünemann; Alla Shapiro; Leif Stenke; Nelson Valverde; David Weinstock; Douglas White; Joseph Albanese; Judith Bader; Elena Buglova; Zhanat Carr; Nelson Chao; C Norman Coleman; Viktor Meineke
Literature review and global consensus on management of acute radiation syndrome affecting nonhematopoietic organ systems.
Disaster medicine and public health preparedness 2011;5(3):183-201.
2011: Richard Hatchett; C Norman Coleman; Nicole Lurie
Health risks of accidents at nuclear power plants.
The New England journal of medicine 2011;365(10):963-4; author reply 964.
2011: Marcy B Grace; Richard Hatchett; Judith L Bader; Kenneth D Cliffer; C Norman Coleman; Gary L Disbrow; Ronald G Manning; John Mercier; Brian R Moyer; Joanna M Prasher; Gerald R Kovacs
The U.S. government's medical countermeasure portfolio management for nuclear and radiological emergencies: synergy from interagency cooperation.
Health physics 2011;101(3):238-47.
2011: C Norman Coleman; Michael A Noska; Steven L Simon; Jana L Telfer; Thomas Bowman
Disaster preparation: lessons from Japan.
Science (New York, N.Y.) 2011;332(6036):1379.
2011: Rocco Casagrande; Nick Wills; Elizabeth Kramer; Louise Sumner; Mark Mussante; Rachel Kurinsky; Patrick McGhee; Luba Katz; David M Weinstock; C Norman Coleman
Using the model of resource and time-based triage (MORTT) to guide scarce resource allocation in the aftermath of a nuclear detonation.
Disaster medicine and public health preparedness 2011;5 Suppl 1():S98-110.
2011: Paula Murrain-Hill; C Norman Coleman; John L Hick; Irwin Redlener; David M Weinstock; John F Koerner; Delaine Black; Melissa Sanders; Judith L Bader; Joseph Forsha; Ann R Knebel
Medical response to a nuclear detonation: creating a playbook for state and local planners and responders.
Disaster medicine and public health preparedness 2011;5 Suppl 1():S89-97.
2011: John L Hick; David M Weinstock; C Norman Coleman; Dan Hanfling; Stephen Cantrill; Irwin Redlener; Judith L Bader; Paula Murrain-Hill; Ann R Knebel
Health care system planning for and response to a nuclear detonation.
Disaster medicine and public health preparedness 2011;5 Suppl 1():S73-88.
2011: J Jaime Caro; Evan G DeRenzo; C Norman Coleman; David M Weinstock; Ann R Knebel
Resource allocation after a nuclear detonation incident: unaltered standards of ethical decision making.
Disaster medicine and public health preparedness 2011;5 Suppl 1():S46-53.
2011: Andrea L DiCarlo; Carmen Maher; John L Hick; Dan Hanfling; Nicholas Dainiak; Nelson Chao; Judith L Bader; C Norman Coleman; David M Weinstock
Radiation injury after a nuclear detonation: medical consequences and the need for scarce resources allocation.
Disaster medicine and public health preparedness 2011;5 Suppl 1():S32-44.
2011: Ann R Knebel; C Norman Coleman; Kenneth D Cliffer; Paula Murrain-Hill; Richard McNally; Victor Oancea; Jimmie Jacobs; Brooke Buddemeier; John L Hick; David M Weinstock; Chad M Hrdina; Tammy Taylor; Marianne Matzo; Judith L Bader; Alicia A Livinski; Gerald Parker; Kevin Yeskey
Allocation of scarce resources after a nuclear detonation: setting the context.
Disaster medicine and public health preparedness 2011;5 Suppl 1():S20-31.
2011: C Norman Coleman; Ann R Knebel; John L Hick; David M Weinstock; Rocco Casagrande; J Jaime Caro; Evan G DeRenzo; Daniel Dodgen; Ann E Norwood; Susan E Sherman; Kenneth D Cliffer; Richard McNally; Judith L Bader; Paula Murrain-Hill
Scarce resources for nuclear detonation: project overview and challenges.
Disaster medicine and public health preparedness 2011;5 Suppl 1():S13-9.
2011: C Norman Coleman; David M Weinstock; Rocco Casagrande; John L Hick; Judith L Bader; Florence Chang; Jeffrey B Nemhauser; Ann R Knebel
Triage and treatment tools for use in a scarce resources-crisis standards of care setting after a nuclear detonation.
Disaster medicine and public health preparedness 2011;5 Suppl 1():S111-21.
2011: C Norman Coleman; Ann R Knebel; Nicole Lurie
Preparing and planning for a catastrophic incident of a nuclear detonation. Foreword.
Disaster medicine and public health preparedness 2011;5 Suppl 1():S11-2.
2011: Horst Romm; Ruth C Wilkins; C Norman Coleman; Patricia K Lillis-Hearne; Terry C Pellmar; Gordon K Livingston; Akio A Awa; Mark S Jenkins; Mitsuaki A Yoshida; Ursula Oestreicher; Pataje G S Prasanna
Biological dosimetry by the triage dicentric chromosome assay: potential implications for treatment of acute radiation syndrome in radiological mass casualties.
Radiation research 2011;175(3):397-404.
2011: Fred A Mettler; David Brenner; C Norman Coleman; Joseph M Kaminski; Ann R Kennedy; Louis K Wagner
Can radiation risks to patients be reduced without reducing radiation exposure? The status of chemical radioprotectants.
AJR. American journal of roentgenology 2011;196(3):616-8.
2011: Benjamin Movsas; Bhadrasain Vikram; Martin Hauer-Jensen; John E Moulder; Ethan Basch; Stephen L Brown; Lisa A Kachnic; Adam P Dicker; C Norman Coleman; Paul Okunieff
Decreasing the adverse effects of cancer therapy: National Cancer Institute guidance for the clinical development of radiation injury mitigators.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(2):222-8.
2011: Daniel G Petereit; Rosemary Wong; B Ashleigh Guadagnolo; C Norman Coleman
Addressing Cancer Disparities Among American Indians through Innovative Technologies and Patient Navigation: The Walking Forward Experience.
Frontiers in oncology 2011;1():11.
2011: J Jaime Caro; C Norman Coleman; Ann Knebel; Evan G DeRenzo
Unaltered ethical standards for individual physicians in the face of drastically reduced resources resulting from an improvised nuclear device event.
The Journal of clinical ethics 2011;22(1):33-41.
2010: Molykutty John-Aryankalayil; Sanjeewani T Palayoor; David Cerna; Charles B Simone; Michael T Falduto; Scott R Magnuson; C Norman Coleman
Fractionated radiation therapy can induce a molecular profile for therapeutic targeting.
Radiation research 2010;174(4):446-58.
2010: Matthew S Davids; Cullen Case; Raymond Hornung; Nelson J Chao; John P Chute; C Norman Coleman; Daniel Weisdorf; Dennis L Confer; David M Weinstock
Assessing surge capacity for radiation victims with marrow toxicity.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2010;16(10):1436-41.
2010: Marcy B Grace; Brian R Moyer; Joanna Prasher; Kenneth D Cliffer; Narayani Ramakrishnan; Joseph Kaminski; C Norman Coleman; Ronald G Manning; Bert W Maidment; Richard Hatchett
Rapid radiation dose assessment for radiological public health emergencies: roles of NIAID and BARDA.
Health physics 2010;98(2):172-8.
2010: C Norman Coleman; Eli Glatstein
The road not taken and choices in radiation oncology.
The oncologist 2010;15(4):332-7.
2009: Kelly A Johnson; C Norman Coleman
Toward radiological preparedness.
Disaster medicine and public health preparedness 2009;3(2):71.
2009: C Norman Coleman; Gerald W Parker
Radiation terrorism: what society needs from the radiobiology-radiation protection and radiation oncology communities.
Journal of radiological protection : official journal of the Society for Radiological Protection 2009;29(2A):A159-69.
2009: Chad M Hrdina; C Norman Coleman; Sandy Bogucki; Judith L Bader; Robert E Hayhurst; Joseph D Forsha; David Marcozzi; Kevin Yeskey; Ann R Knebel
The "RTR" medical response system for nuclear and radiological mass-casualty incidents: a functional TRiage-TReatment-TRansport medical response model.
Prehospital and disaster medicine 2009;24(3):167-78.
2009: Theodor M Fliedner; Nelson J Chao; Judith L Bader; Axel Boettger; Cullen Case; John Chute; Dennis L Confer; Arnold Ganser; Norbert-Claude Gorin; Patrick Gourmelon; Dieter Graessle; Robert Krawisz; Viktor Meineke; Dietger Niederwieser; Matthias Port; Ray Powles; Bhawna Sirohi; David M Weinstock; Albert Wiley; C Norman Coleman
Stem cells, multiorgan failure in radiation emergency medical preparedness: a U.S./European Consultation Workshop.
Stem cells (Dayton, Ohio) 2009;27(5):1205-11.
2009: Bhadrasain Vikram; C Norman Coleman; James A Deye
Current status and future potential of advanced technologies in radiation oncology. Part 2. State of the science by anatomic site.
Oncology (Williston Park, N.Y.) 2009;23(4):380-5.
2009: Todd H Wasserman; C Norman Coleman
Mentors, mensches, and models.
International journal of radiation oncology, biology, physics 2009;73(4):974-5.
2009: Bhadrasain Vikram; C Norman Coleman; James A Deye
Current status and future potential of advanced technologies in radiation oncology. Part 1. Challenges and resources.
Oncology (Williston Park, N.Y.) 2009;23(3):279-83.
2009: C Norman Coleman; Chad Hrdina; Judith L Bader; Ann Norwood; Robert Hayhurst; Joseph Forsha; Kevin Yeskey; Ann Knebel
Medical response to a radiologic/nuclear event: integrated plan from the Office of the Assistant Secretary for Preparedness and Response, Department of Health and Human Services.
Annals of emergency medicine 2009;53(2):213-22.
2009: M Kamrava; Kwong Y Tsang; R A Madan; A Kaushal; C Norman Coleman; J Gulley
Long-term survival and PSA control with radiation and immunotherapy for node positive prostate cancer.
Clinical & developmental immunology 2009;2009():363914.
2009: Molykutty John-Aryankalayil; Sanjeewani T Palayoor; David Cerna; Michael T Falduto; Scott R Magnuson; C Norman Coleman
NS-398, ibuprofen, and cyclooxygenase-2 RNA interference produce significantly different gene expression profiles in prostate cancer cells.
Molecular cancer therapeutics 2009;8(1):261-73.
2008: Sanjeewani T Palayoor; James B Mitchell; David Cerna; William DeGraff; Molykutty John-Aryankalayil; C Norman Coleman
PX-478, an inhibitor of hypoxia-inducible factor-1alpha, enhances radiosensitivity of prostate carcinoma cells.
International journal of cancer. Journal international du cancer 2008;123(10):2430-7.
2008: David M Weinstock; Cullen Case; Judith L Bader; Nelson J Chao; C Norman Coleman; Richard J Hatchett; Daniel J Weisdorf; Dennis L Confer
Radiologic and nuclear events: contingency planning for hematologists/oncologists.
Blood 2008;111(12):5440-5.
2008: Guang Li; Huchen Xie; Holly Ning; Deborah Citrin; Jacek Capala; Roberto Maass-Moreno; Peter Guion; Barbara C Arora; C Norman Coleman; Kevin A Camphausen; Guang Li
Accuracy of 3D volumetric image registration based on CT, MR and PET/CT phantom experiments.
Journal of applied clinical medical physics / American College of Medical Physics 2008;9(4):2781.
2008: Judith L Bader; Jeffrey Nemhauser; Florence Chang; Bijan Mashayekhi; Marti Sczcur; Ann Knebel; Chad Hrdina; C Norman Coleman
Radiation event medical management (REMM): website guidance for health care providers.
Prehospital emergency care : official journal of the National Association of EMS Physicians and the National Association of State EMS Directors 2008;12(1):1-11.
2008: Nicole L Simone; Cynthia Ménard; Benjamin P Soule; Paul S Albert; Peter Guion; Sharon Smith; Denise J Godette; Nancy Sears Crouse; Linda C Sciuto; Theresa Cooley-Zgela; Kevin A Camphausen; C Norman Coleman; anurag singh
Intrarectal amifostine during external beam radiation therapy for prostate cancer produces significant improvements in Quality of Life measured by EPIC score.
International journal of radiation oncology, biology, physics 2008;70(1):90-5.
2007: Mong-Hsun Tsai; John A Cook; Gadisetti V R Chandramouli; William DeGraff; Hailing Yan; Shuping Zhao; C Norman Coleman; James B Mitchell; Eric Y Chuang
Gene expression profiling of breast, prostate, and glioma cells following single versus fractionated doses of radiation.
Cancer research 2007;67(8):3845-52.
2006: anurag singh; Cynthia Ménard; Peter Guion; Nicole L Simone; Sharon Smith; Nancy Sears Crouse; Denise J Godette; Theresa Cooley-Zgela; Linda C Sciuto; Jonathan Coleman; Peter Pinto; Paul S Albert; Kevin A Camphausen; C Norman Coleman
Intrarectal amifostine suspension may protect against acute proctitis during radiation therapy for prostate cancer: a pilot study.
International journal of radiation oncology, biology, physics 2006;65(4):1008-13.
2006: Yuhchyau Chen; Andy Trotti; C Norman Coleman; Mitchell Machtay; Rene O Mirimanoff; John Hay; Peter C O'brien; Brahim El Gueddari; João Victor Salvajoli; Branislav Jeremic
Adverse event reporting and developments in radiation biology after normal tissue injury: International Atomic Energy Agency consultation.
International journal of radiation oncology, biology, physics 2006;64(5):1442-51.
2006: Cynthia Ménard; Donald J Johann; Mark Lowenthal; Thierry Muanza; Mary Sproull; Sally Ross; James L Gulley; Emanuel F Petricoin; C Norman Coleman; Gordon R Whiteley; Lance A Liotta; Kevin A Camphausen
Discovering clinical biomarkers of ionizing radiation exposure with serum proteomic analysis.
Cancer research 2006;66(3):1844-50.
2006: Mong-Hsun Tsai; Xinbin Chen; Gadisetti V R Chandramouli; Yidong Chen; H Yan; S Zhao; P Keng; H L Liber; C Norman Coleman; James B Mitchell; Eric Y Chuang
Transcriptional responses to ionizing radiation reveal that p53R2 protects against radiation-induced mutagenesis in human lymphoblastoid cells.
Oncogene 2006;25(4):622-32.
2006: anurag singh; Peter Guion; Robert C Susil; Deborah Citrin; Holly Ning; Robert W Miller; Karen Ullman; Sharon Smith; Nancy Sears Crouse; Denise J Godette; Bronwyn R Stall; C Norman Coleman; Kevin A Camphausen; Cynthia Ménard
Early observed transient prostate-specific antigen elevations on a pilot study of external beam radiation therapy and fractionated MRI guided high dose rate brachytherapy boost.
Radiation oncology (London, England) 2006;1():28.
2006: Karen Ullman; Holly Ning; Robert C Susil; Asna Ayele; Lucresse Jocelyn; Jan Havelos; Peter Guion; Huchen Xie; Guang Li; Barbara C Arora; Angela Cannon; Guang Li; C Norman Coleman; Kevin A Camphausen; Cynthia Ménard
Intra- and inter-radiation therapist reproducibility of daily isocenter verification using prostatic fiducial markers.
Radiation oncology (London, England) 2006;1():2.
2006: Robert C Susil; Cynthia Ménard; Axel Krieger; Jonathan Coleman; Kevin A Camphausen; Peter Choyke; Gabor Fichtinger; Louis L Whitcomb; C Norman Coleman; Ergin Atalar
Transrectal prostate biopsy and fiducial marker placement in a standard 1.5T magnetic resonance imaging scanner.
The Journal of urology 2006;175(1):113-20.
2005: Sanjeewani T Palayoor; Moly J Arayankalayil; Azadeh Shoaibi; C Norman Coleman
Radiation sensitivity of human carcinoma cells transfected with small interfering RNA targeted against cyclooxygenase-2.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(19 Pt 1):6980-6.
2005: Guang Li; Huchen Xie; Holly Ning; Jacek Capala; Barbara C Arora; C Norman Coleman; Kevin A Camphausen; Guang Li
A novel 3D volumetric voxel registration technique for volume-view-guided image registration of multiple imaging modalities.
International journal of radiation oncology, biology, physics 2005;63(1):261-73.
2005: Thierry Muanza; Paul S Albert; Sharon Smith; Denise J Godette; Nancy Sears Crouse; Theresa Cooley-Zgela; Linda C Sciuto; Kevin A Camphausen; C Norman Coleman; Cynthia Ménard
Comparing measures of acute bowel toxicity in patients with prostate cancer treated with external beam radiation therapy.
International journal of radiation oncology, biology, physics 2005;62(5):1316-21.
2005: Thierry Muanza; Ana P Cotrim; Mathew McAuliffe; Anastasia L Sowers; Bruce J Baum; John A Cook; Felix Feldchtein; Paul Amazeen; C Norman Coleman; James B Mitchell
Evaluation of radiation-induced oral mucositis by optical coherence tomography.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(14):5121-7.
2005: Chie Kudo-Saito; Jeffrey Schlom; Kevin A Camphausen; C Norman Coleman; James W Hodge
The requirement of multimodal therapy (vaccine, local tumor radiation, and reduction of suppressor cells) to eliminate established tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(12):4533-44.
2005: James L Gulley; Philip M Arlen; Anne Bastian; Steven Morin; Jennifer Marte; Patricia Beetham; Kwong-Yok Tsang; Junko Yokokawa; James W Hodge; Cynthia Ménard; Kevin A Camphausen; C Norman Coleman; Francis Sullivan; Seth M Steinberg; Jeffrey Schlom; William Dahut
Combining a recombinant cancer vaccine with standard definitive radiotherapy in patients with localized prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(9):3353-62.
2005: Deborah Citrin; Holly Ning; Peter Guion; Guang Li; Robert C Susil; Guang Li; Etienne Lessard; Jean Pouliot; Xie Huchen; Jacek Capala; C Norman Coleman; Kevin A Camphausen; Cynthia Ménard
Inverse treatment planning based on MRI for HDR prostate brachytherapy.
International journal of radiation oncology, biology, physics 2005;61(4):1267-75.
2005: Mong-Hsun Tsai; Hailing Yan; Xi Chen; Gadisetti V R Chandramouli; Shuping Zhao; Deborah Coffin; C Norman Coleman; James B Mitchell; Eric Y Chuang
Evaluation of hybridization conditions for spotted oligonucleotide-based DNA microarrays.
Molecular biotechnology 2005;29(3):221-4.
2005: Cynthia Ménard; Robert C Susil; Peter Choyke; Jonathan Coleman; Robert L Grubb; Ahmed Gharib; Axel Krieger; Peter Guion; David Thomasson; Karen Ullman; Sandeep N Gupta; Virginia Espina; Lance A Liotta; Emanuel F Petricoin; Gabor Fitchtinger; Louis L Whitcomb; Ergin Atalar; C Norman Coleman; Kevin A Camphausen
An interventional magnetic resonance imaging technique for the molecular characterization of intraprostatic dynamic contrast enhancement.
Molecular imaging 2005;4(1):63-6.
2005: Daniel G Petereit; Deborah Rogers; Linda Burhansstipanov; Judith Kaur; Frank Govern; Steve P Howard; Christen H Osburn; C Norman Coleman; Jack F Fowler; Richard Chappell; Minesh Mehta
Walking forward: the South Dakota Native American project.
Journal of cancer education : the official journal of the American Association for Cancer Education 2005;20(1 Suppl):65-70.
2004: Helen B Stone; John E Moulder; C Norman Coleman; K. Kian Ang; Mitchell S. Anscher; Mary Helen Barcellos-Hoff; William S Dynan; John R Fike; David J Grdina; Joel S Greenberger; Martin Hauer-Jensen; Richard P Hill; Richard Kolesnick; Thomas J MacVittie; Cheryl Marks; william mcbride; Noelle Metting; Terry Pellmar; Mary Purucker; Mike E Robbins; Robert H Schiestl; Thomas M Seed; Joseph E Tomaszewski; Elizabeth L Travis; Paul E Wallner; Mary Wolpert; Daniel W Zaharevitz
Models for evaluating agents intended for the prophylaxis, mitigation and treatment of radiation injuries. Report of an NCI Workshop, December 3-4, 2003.
Radiation research 2004;162(6):711-28.
2004: Daniel G Petereit; Deborah Rogers; Frank Govern; C Norman Coleman; Christen H Osburn; Steve P Howard; Judith Kaur; Linda Burhansstipanov; C Jack F Fowler; Richard Chappell; Minesh Mehta
Increasing access to clinical cancer trials and emerging technologies for minority populations: the Native American Project.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(22):4452-5.
2004: Paul E Wallner; C Norman Coleman; Martin W Brechbiel; Diane E Milenic; Prabhakar Tripuraneni
Are radiation oncologists serious about systemic radiation therapy and if not, should we be?
International journal of radiation oncology, biology, physics 2004;60(1):1-2.
2004: Robert C Susil; Kevin A Camphausen; Peter Choyke; Elliot R McVeigh; Gary S Gustafson; Holly Ning; Robert W Miller; Ergin Atalar; C Norman Coleman; Cynthia Ménard
System for prostate brachytherapy and biopsy in a standard 1.5 T MRI scanner.
Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine 2004;52(3):683-7.
2004: Cynthia Ménard; Robert C Susil; Peter Choyke; Gary S Gustafson; William Kammerer; Holly Ning; Robert W Miller; Karen Ullman; Nancy Sears-Crouse; Sharon Smith; Etienne Lessard; Jean Pouliot; Victor Wright; Elliot R McVeigh; C Norman Coleman; Kevin A Camphausen
MRI-guided HDR prostate brachytherapy in standard 1.5T scanner.
International journal of radiation oncology, biology, physics 2004;59(5):1414-23.
2004: Sanjeewani T Palayoor; Melissa A Burgos; Azadeh Shoaibi; Philip J Tofilon; C Norman Coleman
Effect of radiation and ibuprofen on normoxic renal carcinoma cells overexpressing hypoxia-inducible factors by loss of von Hippel-Lindau tumor suppressor gene function.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(12 Pt 1):4158-64.
2004: Mala Chakraborty; Scott I Abrams; C Norman Coleman; Kevin A Camphausen; Jeffrey Schlom; James W Hodge
External beam radiation of tumors alters phenotype of tumor cells to render them susceptible to vaccine-mediated T-cell killing.
Cancer research 2004;64(12):4328-37.
2004: Jamie K Waselenko; Thomas J MacVittie; William F Blakely; Nicki Pesik; Albert L Wiley; William E Dickerson; Horace Tsu; Dennis L Confer; C Norman Coleman; Thomas Seed; Patrick Lowry; James O Armitage; Nicholas Dainiak
Medical management of the acute radiation syndrome: recommendations of the Strategic National Stockpile Radiation Working Group.
Annals of internal medicine 2004;140(12):1037-51.
2004: Paul Okunieff; Elizabeth Augustine; Jeanne E Hicks; Terri L Cornelison; Rosemary M Altemus; Boris G Naydich; Ivan Ding; Amy K Huser; Edward H Abraham; Judith J Smith; C Norman Coleman; Lynn H Gerber
Pentoxifylline in the treatment of radiation-induced fibrosis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(11):2207-13.
2004: C Norman Coleman; Helen B Stone; John E Moulder; Terry Pellmar
Medicine. Modulation of radiation injury.
Science (New York, N.Y.) 2004;304(5671):693-4.
2004: Kevin A Camphausen; Cynthia Ménard; Mary Sproull; Elizabeth Goley; Samar Basu; C Norman Coleman
Isoprostane levels in the urine of patients with prostate cancer receiving radiotherapy are not elevated.
International journal of radiation oncology, biology, physics 2004;58(5):1536-9.
2004: Paul E Wallner; Douglas W. Arthur; H Bartelink; J Connolly; Gregory Edmundson; Armando Giuliano; Neal Goldstein; James M Hevezi; Thomas B Julian; Robert R Kuske; Allen S Lichter; Beryl Mc Cormick; R Orecchia; Lori J Pierce; Simon Nicholas Powell; Lawrence J Solin; Frank Vicini; T Whelan; John Wong; C Norman Coleman
Workshop on partial breast irradiation: state of the art and the science, Bethesda, MD, December 8-10, 2002.
Journal of the National Cancer Institute 2004;96(3):175-84.
2004: Linda W Chan; Marsha A Moses; Elizabeth Goley; Mary Sproull; Thierry Muanza; C Norman Coleman; William D Figg; Paul S Albert; Cynthia Ménard; Kevin A Camphausen
Urinary VEGF and MMP levels as predictive markers of 1-year progression-free survival in cancer patients treated with radiation therapy: a longitudinal study of protein kinetics throughout tumor progression and therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(3):499-506.
2004: C Norman Coleman
International Conference on Translational Research ICTR 2003 Conference Summary: marshalling resources in a complex time.
International journal of radiation oncology, biology, physics 2004;58(2):307-19.
2003: Cynthia Ménard; Kevin A Camphausen; Thierry Muanza; Nancy Sears-Crouse; Sharon Smith; Edgar Ben-Josef; C Norman Coleman
Clinical trial of endorectal amifostine for radioprotection in patients with prostate cancer: rationale and early results.
Seminars in oncology 2003;30(6 Suppl 18):63-7.
2003: C Norman Coleman; Helen B Stone; George A Alexander; Mary Helen Barcellos-Hoff; Joel S Bedford; Robert G Bristow; Joseph R Dynlacht; Zvi Fuks; Lester S Gorelic; Richard P Hill; Michael Charles Joiner; Fei-Fei Liu; william mcbride; W Gillies McKenna; Simon Nicholas Powell; Mike E Robbins; Sara Rockwell; Peter B Schiff; Edward G Shaw; Dietmar W Siemann; Elizabeth L Travis; Paul E Wallner; Rosemary S L Wong; Elaine Zeman
Education and training for radiation scientists: radiation research program and American Society of Therapeutic Radiology and Oncology Workshop, Bethesda, Maryland, May 12-14, 2003.
Radiation research 2003;160(6):729-37.
2003: Kevin A Camphausen; Mary Sproull; Steve Tantama; Sandeep Sankineni; Tamalee Scott; Cynthia Ménard; C Norman Coleman; Martin W Brechbiel
Evaluation of copper chelation agents as anti-angiogenic therapy.
Bioorganic & medicinal chemistry 2003;11(19):4287-93.
2003: Philip J Tofilon; Scott Saxman; C Norman Coleman
Molecular targets for radiation therapy: bringing preclinical data into clinical trials.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(10 Pt 1):3518-20.
2003: Helen B Stone; C Norman Coleman; Mitchell S. Anscher; william mcbride
Effects of radiation on normal tissue: consequences and mechanisms.
The lancet oncology 2003;4(9):529-36.
2003: C Norman Coleman; Paul E Wallner; Jeffrey S Abrams
Inflammatory breast issue.
Journal of the National Cancer Institute 2003;95(16):1182-3.
2003: Sanjeewani T Palayoor; Philip J Tofilon; C Norman Coleman
Ibuprofen-mediated reduction of hypoxia-inducible factors HIF-1alpha and HIF-2alpha in prostate cancer cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(8):3150-7.
2003: Andy Trotti; A Dimitrios Colevas; Ann Setser; Valerie W Rusch; David Jaques; Volker Budach; Corey Langer; Barbara Murphy; Richard Cumberlin; C Norman Coleman; Philip Rubin
CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment.
Seminars in radiation oncology 2003;13(3):176-81.
2003: C Norman Coleman
Linking radiation oncology and imaging through molecular biology (or now that therapy and diagnosis have separated, it's time to get together again!).
Radiology 2003;228(1):29-35.
2003: Mala Chakraborty; Scott I Abrams; Kevin A Camphausen; Kebin Liu; Tamalee Scott; C Norman Coleman; James W Hodge
Irradiation of tumor cells up-regulates Fas and enhances CTL lytic activity and CTL adoptive immunotherapy.
Journal of immunology (Baltimore, Md. : 1950) 2003;170(12):6338-47.
2003: C Norman Coleman; William F Blakely; John R Fike; Thomas J MacVittie; Noelle F Metting; James B Mitchell; John E Moulder; R Julian Preston; Thomas M Seed; Helen B Stone; Philip J Tofilon; Rosemary S L Wong
Molecular and cellular biology of moderate-dose (1-10 Gy) radiation and potential mechanisms of radiation protection: report of a workshop at Bethesda, Maryland, December 17-18, 2001.
Radiation research 2003;159(6):812-34.
2003: A Dimitrios Colevas; J Martin Brown; Stephen Hahn; James Mitchell; Kevin A Camphausen; C Norman Coleman
Development of investigational radiation modifiers.
Journal of the National Cancer Institute 2003;95(9):646-51.
2003: Karen Marcus; Sharon C Dutton; Patrick Barnes; C Norman Coleman; Scott L Pomeroy; Liliana C Goumnerova; Amy L Billett; Mark W Kieran; Nancy J Tarbell
A phase I trial of etanidazole and hyperfractionated radiotherapy in children with diffuse brainstem glioma.
International journal of radiation oncology, biology, physics 2003;55(5):1182-5.
2002: David Gius; C Norman Coleman
Treatment of nasopharyngeal cancer: raising the "Barr".
Journal of the National Cancer Institute 2002;94(21):1594-5.
2002: C Norman Coleman; Laura Kelly; Nancy Riese Daly; Clair Beard; Irving Kaplan; Carolyn Lamb; Kathleen J Propert; Judith Manola
Phase III study of ibuprofen versus placebo for radiation-induced genitourinary side effects.
International journal of radiation oncology, biology, physics 2002;54(1):191-4.
2002: Richard L Cumberlin; C Norman Coleman
New directions in brachytherapy.
International journal of radiation oncology, biology, physics 2002;53(1):6-11.
2002: Helen B Stone; william mcbride; C Norman Coleman
Modifying normal tissue damage postirradiation. Report of a workshop sponsored by the Radiation Research Program, National Cancer Institute, Bethesda, Maryland, September 6-8, 2000.
Radiation research 2002;157(2):204-23.
2002: C Norman Coleman; James B Mitchell; Kevin A Camphausen
Tumor hypoxia: chicken, egg, or a piece of the farm?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(3):610-5.
2002: Matthew M Poggi; Peijie J Cong; C Norman Coleman; Elaine S Jaffe
Low-grade follicular lymphoma of the small intestine.
Journal of clinical gastroenterology 2002;34(2):155-9.
2002: C Norman Coleman
Radiation oncology--linking technology and biology in the treatment of cancer.
Acta oncologica (Stockholm, Sweden) 2002;41(1):6-13.
2001: Matthew M Poggi; C Norman Coleman; James B Mitchell
Sensitizers and protectors of radiation and chemotherapy.
Current problems in cancer 2001;25(6):334-411.
2001: C Norman Coleman
Young Investigators Workshop--Radiation Research Program, Radiation Oncology Sciences Program, National Cancer Institute, NIH, August 1-2 2000.
International journal of radiation oncology, biology, physics 2001;49(5):1505-16.
2001: C Norman Coleman
Investing in our future: listening to those who will take us where we need to go.
International journal of radiation oncology, biology, physics 2001;49(5):1211.
2001: Richard L Cumberlin; C Norman Coleman
Research in medical physics.
International journal of radiation oncology, biology, physics 2001;49(3):891-5.
2001: C Norman Coleman; Richard L Cumberlin
Translational research in radiation oncology.
International journal of radiation oncology, biology, physics 2001;49(3):885-90.
2001: C Norman Coleman; Richard L Cumberlin
We're from the government and we're here to help you.
International journal of radiation oncology, biology, physics 2001;49(3):617-8.
2001: C Norman Coleman
International Conference on Translational Research and Preclinical Strategies in Radio-Oncology (ICTR)--conference summary.
International journal of radiation oncology, biology, physics 2001;49(2):301-9.
2000: C Norman Coleman; Frank Govern; G Svensson; R Mitchell; J T Chaffey
The Harvard Joint Center for Radiation Therapy, 1968-1999: a unique concept and its relationship to the prevailing times in academic medicine.
International journal of radiation oncology, biology, physics 2000;47(5):1357-69.
2000: David H Hussey; R H Sagerman; F Halberg; A Dubey; C Norman Coleman
Report of the 1997 SCAROP survey on resident training. Society of Chairmen of Academic Radiation Oncology Programs.
Academic radiology 2000;7(3):176-83.
1999: Sanjeewani T Palayoor; M Y Youmell; Stuart K Calderwood; C Norman Coleman; Brendan Price
Constitutive activation of IkappaB kinase alpha and NF-kappaB in prostate cancer cells is inhibited by ibuprofen.
Oncogene 1999;18(51):7389-94.
1999: Mary Ann Stevenson; Mei Juan Zhao; Alexzander Asea; C Norman Coleman; Stuart K Calderwood
Salicylic acid and aspirin inhibit the activity of RSK2 kinase and repress RSK2-dependent transcription of cyclic AMP response element binding protein- and NF-kappa B-responsive genes.
Journal of immunology (Baltimore, Md. : 1950) 1999;163(10):5608-16.
1999: Larry N Shulman; L Buswell; NE Riese; N Doherty; Jay S Loeffler; R W von Roemeling; C Norman Coleman
Phase I trial of the hypoxic cell cytotoxin tirapazamine with concurrent radiation therapy in the treatment of refractory solid tumors.
International journal of radiation oncology, biology, physics 1999;44(2):349-53.
1999: C Norman Coleman
Molecular biology in radiation oncology. Radiation oncology perspective of BRCA1 and BRCA2.
Acta oncologica (Stockholm, Sweden) 1999;38 Suppl 13():55-9.
1999: Anthony V D'Amico; Richard Whittington; S Bruce Malkowicz; J Fondurulia; M H Chen; Irving Kaplan; Clair Beard; John E Tomaszewski; Andrew A Renshaw; Alan Wein; C Norman Coleman
Pretreatment nomogram for prostate-specific antigen recurrence after radical prostatectomy or external-beam radiation therapy for clinically localized prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(1):168-72.
1999: C Norman Coleman; J B Mitchell
Clinical radiosensitization: why it does and does not work.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(1):1-3.
1998: Rita M Linggood; Frank Govern; C Norman Coleman
A blueprint for linking academic oncology and the community.
Journal of health politics, policy and law 1998;23(6):973-94.
1998: C Norman Coleman
Chemical sensitizers and protectors.
International journal of radiation oncology, biology, physics 1998;42(4):781-3.
1998: Anthony V D'Amico; Robert Cormack; Clare M C Tempany; Sanjaya Kumar; George P Topulos; Hanne M Kooy; C Norman Coleman
Real-time magnetic resonance image-guided interstitial brachytherapy in the treatment of select patients with clinically localized prostate cancer.
International journal of radiation oncology, biology, physics 1998;42(3):507-15.
1998: Beverly A Teicher; G Ara; Y N Chen; A Recht; C Norman Coleman
Interaction of tomudex with radiation in vitro and in vivo.
International journal of oncology 1998;13(3):437-42.
1998: Helen B Stone; W C Dewey; S S Wallace; C Norman Coleman
Molecular Biology to Radiation Oncology: A Model for Translational Research? Opportunities in basic and translational research. From a workshop sponsored by the National Cancer Institute, Radiation Research Program, January 26-28, 1997, Bethesda, Maryland.
Radiation research 1998;150(2):134-47.
1998: C Norman Coleman; J R Harris
Current scientific issues related to clinical radiation oncology.
Radiation research 1998;150(2):125-33.
1998: Anthony D Elias; C Wheeler; Lois Jeanne Ayash; Gary Schwartz; Joseph G Ibrahim; L Mills; Mary McCauley; C Norman Coleman; Diane Warren; Lowell E Schnipper; Karen Antman; Beverly A Teicher; Emil Frei
Dose escalation of the hypoxic cell sensitizer etanidazole combined with ifosfamide, carboplatin, etoposide, and autologous hematopoietic stem cell support.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(6):1443-9.
1998: Sanjeewani T Palayoor; EA Bump; Stuart K Calderwood; S Bartol; C Norman Coleman
Combined antitumor effect of radiation and ibuprofen in human prostate carcinoma cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(3):763-71.
1998: C Norman Coleman
Of what use is molecular biology to the practicing radiation oncologist?
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1998;46(2):117-25.
1998: Anthony V D'Amico; Richard Whittington; Irving Kaplan; Clair Beard; Delray Schultz; S Bruce Malkowicz; Alan Wein; John E Tomaszewski; C Norman Coleman
Calculated prostate carcinoma volume: The optimal predictor of 3-year prostate specific antigen (PSA) failure free survival after surgery or radiation therapy of patients with pretreatment PSA levels of 4-20 nanograms per milliliter.
Cancer 1998;82(2):334-41.
1998: E L Chang; Jay S Loeffler; NE Riese; Patrick Y Wen; E Alexander; P M Black; C Norman Coleman
Survival results from a phase I study of etanidazole (SR2508) and radiotherapy in patients with malignant glioma.
International journal of radiation oncology, biology, physics 1998;40(1):65-70.
1997: NE Riese; L Buswell; L Noll; T F Pajak; J Stetz; D J Lee; C Norman Coleman
Pharmacokinetic monitoring and dose modification of etanidazole in the RTOG 85-27 phase III head and neck trial.
International journal of radiation oncology, biology, physics 1997;39(4):855-8.
1997: L Hughes-Davies; Nancy J Tarbell; C Norman Coleman; Barbara Silver; Larry N Shulman; Rita M Linggood; George P Canellos; Peter M Mauch
Stage IA-IIB Hodgkin's disease: management and outcome of extensive thoracic involvement.
International journal of radiation oncology, biology, physics 1997;39(2):361-9.
1997: Anthony V D'Amico; Richard Whittington; Irving Kaplan; Clair Beard; Delray Schultz; S Bruce Malkowicz; John E Tomaszewski; Alan Wein; C Norman Coleman
Equivalent 5-year bNED in select prostate cancer patients managed with surgery or radiation therapy despite exclusion of the seminal vesicles from the CTV.
International journal of radiation oncology, biology, physics 1997;39(2):335-40.
1997: Sanjeewani T Palayoor; EA Bump; B A Teicher; C Norman Coleman
Apoptosis and clonogenic cell death in PC3 human prostate cancer cells after treatment with gamma radiation and suramin.
Radiation research 1997;148(2):105-14.
1997: Anthony V D'Amico; Richard Whittington; Irving Kaplan; Clair Beard; MR Jiroutek; S Bruce Malkowicz; Alan Wein; C Norman Coleman
Equivalent biochemical failure-free survival after external beam radiation therapy or radical prostatectomy in patients with a pretreatment prostate specific antigen of > 4-20 ng/ml.
International journal of radiation oncology, biology, physics 1997;37(5):1053-8.
1996: Colleen A Lawton; C Norman Coleman; J W Buzydlowski; Jeffrey D Forman; V A Marcial; John Del Rowe; Marvin Rotman
Results of a phase II trial of external beam radiation with etanidazole (SR 2508) for the treatment of locally advanced prostate cancer (RTOG Protocol 90-20).
International journal of radiation oncology, biology, physics 1996;36(3):673-80.
1996: C Norman Coleman
Conference summary: the ninth international conference on the Chemical Modifiers of Cancer Treatment.
The British journal of cancer. Supplement 1996;27():S297-304.
1996: Lynn Hlatky; Philip Hahnfeldt; C Tsionou; C Norman Coleman
Vascular endothelial growth factor: environmental controls and effects in angiogenesis.
The British journal of cancer. Supplement 1996;27():S151-6.
1996: Sanjeewani T Palayoor; EA Bump; DM Saroff; J R Delfs; Changiz Geula; L Menton-Brennan; S J Hurwitz; C Norman Coleman; Mary Ann Stevenson
Effect of BSO and etanidazole on neurofilament degradation in neonatal rat spinal cord cultures.
The British journal of cancer. Supplement 1996;27():S117-21.
1996: C Norman Coleman; T W Griffin; L R Prosnitz; R T Hoppe; J S Cooper
Training the radiation oncologist for the twenty-first century.
International journal of radiation oncology, biology, physics 1996;35(4):821-6.
1996: Peter M Mauch; L A Kalish; Karen Marcus; C Norman Coleman; Larry N Shulman; E Krill; Steven E Come; Barbara Silver; George P Canellos; Nancy J Tarbell
Second malignancies after treatment for laparotomy staged IA-IIIB Hodgkin's disease: long-term analysis of risk factors and outcome.
Blood 1996;87(9):3625-32.
1996: C Norman Coleman; Mary Ann Stevenson
Biologic basis for radiation oncology.
Oncology (Williston Park, N.Y.) 1996;10(3):399-411; discussion: 411-5.
1996: S P Howard; S J Park; L Hughes-Davies; C Norman Coleman; Brendan Price
Suramin increases p53 protein levels but does not activate the p53-dependent G1 checkpoint.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(2):269-76.
1996: Clair Beard; Peter Kijewski; M Bussière; Rebecca Gelman; D Gladstone; K Shaffer; M Plunkett; P Castello; C Norman Coleman
Analysis of prostate and seminal vesicle motion: implications for treatment planning.
International journal of radiation oncology, biology, physics 1996;34(2):451-8.
1996: C Norman Coleman; Mary Ann Stevenson
Advances in cellular and molecular radiation oncology.
Urologic oncology 1996;2(1):3-13.
1996: Julia S Wong; G Ara; SR Keyes; Roy S Herbst; C Norman Coleman; Beverly A Teicher
Lisofylline as a modifier of radiation therapy.
Oncology research 1996;8(12):513-8.
1996: C Norman Coleman
Modulating the radiation response.
Stem cells (Dayton, Ohio) 1996;14(1):10-5.
1996: Anthony V D'Amico; C Norman Coleman
Role of interstitial radiotherapy in the management of clinically organ-confined prostate cancer: the jury is still out.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(1):304-15.
1995: R E Langley; S G Quartuccio; P T Kennealey; C Norman Coleman; EA Bump
Effect of cell cycle stage, dose rate and repair of sublethal damage on radiation-induced apoptosis in F9 teratocarcinoma cells.
Radiation research 1995;144(1):90-6.
1995: J S Loeffler; D C Shrieve; C Norman Coleman
Chemoradiation and adjuvant chemotherapy for glioblastoma: why does so much therapy yield so little improvement in survival?
International journal of radiation oncology, biology, physics 1995;33(2):531-3.
1995: C Norman Coleman
"Reports of my death [may be] greatly exaggerated" (adapted from Mark Twain)--in response to Dr. J. M. Brown, IJROBP 32:883-885; 1995.
International journal of radiation oncology, biology, physics 1995;32(4):1264-5.
1995: BA Bornstein; T S Herman; Jorgen Hansen; L Buswell; P S Zouranjian; S M Fraser; B A Teicher; G K Svensson; C Norman Coleman
Pilot study of local hyperthermia, radiation therapy, etanidazole, and cisplatin for advanced superficial tumours.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 1995;11(4):489-99.
1995: J R Wong; C Ho; Peter M Mauch; C Norman Coleman; S Berman; Lan Bo Chen
Removal of carcinoma cells from contaminated bone marrow using the lipophilic cation rhodamine 123.
Clinical cancer research : an official journal of the American Association for Cancer Research 1995;1(6):621-30.
1995: Peter M Mauch; L A Kalish; Karen Marcus; Larry N Shulman; E Krill; Nancy J Tarbell; Barbara Silver; H Weinstein; Steven E Come; George P Canellos; C Norman Coleman
Long-term survival in Hodgkin's disease relative impact of mortality, second tumors, infection, and cardiovascular disease.
The cancer journal from Scientific American 1995;1(1):33-42.
1995: Peter M Mauch; George P Canellos; Larry N Shulman; Barbara Silver; Nancy J Tarbell; Steven E Come; Michael S Rabin; C Norman Coleman
Mantle irradiation alone for selected patients with laparotomy-staged IA to IIA Hodgkin's disease: preliminary results of a prospective trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(4):947-52.
1995: Sanjeewani T Palayoor; R M Macklis; EA Bump; C Norman Coleman
Modulation of radiation-induced apoptosis and G2/M block in murine T-lymphoma cells.
Radiation research 1995;141(3):235-43.
1994: Karen Marcus; L A Kalish; C Norman Coleman; Larry N Shulman; D S Rosenthal; George P Canellos; Peter M Mauch
Improved survival in patients with limited stage IIIA Hodgkin's disease treated with combined radiation therapy and chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(12):2567-72.
1994: C Norman Coleman; M A Stevenson
The hall-mark of modern radiation oncology.
International journal of radiation oncology, biology, physics 1994;30(5):1247-9.
1994: Lynn Hlatky; C Tsionou; Philip Hahnfeldt; C Norman Coleman
Mammary fibroblasts may influence breast tumor angiogenesis via hypoxia-induced vascular endothelial growth factor up-regulation and protein expression.
Cancer research 1994;54(23):6083-6.
1994: Laurie L Herscher; Murali K Cherukuri; John A Cook; C Norman Coleman; J E Biaglow; S W Tuttle; Frank J Gonzalez; James B Mitchell
Protection against SR 4233 (Tirapazamine) aerobic cytotoxicity by the metal chelators desferrioxamine and tiron.
International journal of radiation oncology, biology, physics 1994;30(4):879-85.
1994: G Ara; C Norman Coleman; Beverly A Teicher
SR-4233 (Tirapazamine) acts as an uncoupler of oxidative phosphorylation in human MCF-7 breast carcinoma cells.
Cancer letters 1994;85(2):195-203.
1994: I Kaplan; C Norman Coleman
Re: The value of serial prostate specific antigen determinations 5 years after radiotherapy: steeply increasing values characterize 80% of patients.
The Journal of urology 1994;152(2 Pt 1):493-5.
1994: Patrick Y Wen; E Alexander; Peter Black; H A Fine; N Riese; J M Levin; C Norman Coleman; Jay S Loeffler
Long term results of stereotactic brachytherapy used in the initial treatment of patients with glioblastomas.
Cancer 1994;73(12):3029-36.
1994: N E Riese; Jay S Loeffler; Patrick Y Wen; E Alexander; Peter Black; C Norman Coleman
A phase I study of etanidazole and radiotherapy in malignant glioma.
International journal of radiation oncology, biology, physics 1994;29(3):617-20.
1994: Larry N Shulman; L Buswell; H Goodman; MG Muto; R Berkowitz; B Teicher; T Kusumoto; S J Hurwitz; L A Kalish; C Norman Coleman
Phase I pharmacokinetic study of the hypoxic cell sensitizer etanidazole with carboplatin and cyclophosphamide in the treatment of advanced ovarian cancer.
International journal of radiation oncology, biology, physics 1994;29(3):545-8.
1994: Larry N Shulman; L Buswell; L A Kalish; C Norman Coleman
Use of the hypoxic cell sensitizer etanidazole (SR-2508) with intravenous melphalan and prednisone in the treatment of multiple myeloma: a pharmacokinetic study.
International journal of radiation oncology, biology, physics 1994;29(3):541-3.
1994: L Buswell; Abram Recht; J Clark; T Ravikumar; Paul Busse; C Norman Coleman
Combined-modality therapy of esophageal cancer with radiotherapy, etanidazole, and cisplatin-fluorouracil, with or without surgery: neurotoxicity, other toxicities and outcome.
International journal of radiation oncology, biology, physics 1994;29(3):535-40.
1994: Clair Beard; L Buswell; M A Rose; L Noll; D Johnson; C Norman Coleman
Phase II trial of external beam radiation with etanidazole (SR 2508) for the treatment of locally advanced prostate cancer.
International journal of radiation oncology, biology, physics 1994;29(3):611-6.
1994: N Doherty; S L Hancock; S Kaye; C Norman Coleman; L Shulman; C Marquez; C Mariscal; Roy Rampling; S Senan; R V Roemeling
Muscle cramping in phase I clinical trials of tirapazamine (SR 4233) with and without radiation.
International journal of radiation oncology, biology, physics 1994;29(2):379-82.
1994: Stephen W Tuttle; L Hazard; Cameron J Koch; James B Mitchell; C Norman Coleman; John E Biaglow
Bioreductive metabolism of SR-4233 (WIN 59075) by whole cell suspensions under aerobic and hypoxic conditions: role of the pentose cycle and implications for the mechanism of cytotoxicity observed in air.
International journal of radiation oncology, biology, physics 1994;29(2):357-62.
1994: Sanjeewani T Palayoor; EA Bump; K Malaker; R E Langley; DM Saroff; J R Delfs; S J Hurwitz; C Norman Coleman
Modification of the aerobic cytotoxicity of etanidazole.
International journal of radiation oncology, biology, physics 1994;29(2):289-93.
1994: EA Bump; S J Braunhut; Sanjeewani T Palayoor; D Medeiros; L L Lai; B A Cerce; R E Langley; C Norman Coleman
Novel concepts in modification of radiation sensitivity.
International journal of radiation oncology, biology, physics 1994;29(2):249-53.
1994: K Malaker; S J Hurwitz; EA Bump; O W Griffith; L L Lai; N Riese; C Norman Coleman
Pharmacodynamics of prolonged treatment with L,S-buthionine sulfoximine.
International journal of radiation oncology, biology, physics 1994;29(2):407-12.
1994: R E Langley; Sanjeewani T Palayoor; C Norman Coleman; EA Bump
Radiation-induced apoptosis in F9 teratocarcinoma cells.
International journal of radiation biology 1994;65(5):605-10.
1994: C Norman Coleman; Clair Beard; Philip W Kantoff; Rebecca Gelman
Rate of relapse following treatment for localized prostate cancer: a critical analysis of retrospective reports.
International journal of radiation oncology, biology, physics 1994;28(1):303-13.
1994: F E Halberg; D Cosmatis; L L Gunderson; R D Noyes; G R Hanks; L Buswell; D M Nagorney; C Norman Coleman
RTOG #89-06: a phase I study to evaluate intraoperative radiation therapy and the hypoxic cell sensitizer etanidazole in locally advanced malignancies.
International journal of radiation oncology, biology, physics 1994;28(1):201-6.
1994: Mary Ann Stevenson; S S Pollock; C Norman Coleman; Stuart K Calderwood
X-irradiation, phorbol esters, and H2O2 stimulate mitogen-activated protein kinase activity in NIH-3T3 cells through the formation of reactive oxygen intermediates.
Cancer research 1994;54(1):12-5.
1994: C Norman Coleman
Carcinoma of the prostate: praising Stanford's accomplishments.
International journal of radiation oncology, biology, physics 1994;28(1):321-4; discussion 327.
1993: R E Langley; Sanjeewani T Palayoor; C Norman Coleman; EA Bump
Modifiers of radiation-induced apoptosis.
Radiation research 1993;136(3):320-6.
1993: K T Kelsey; M Caggana; Peter M Mauch; C Norman Coleman; J R Clark; Howard Liber
Mutagenesis after cancer therapy.
Environmental health perspectives 1993;101 Suppl 3():177-84.
1993: C J Beard; I D Kaplan; C Norman Coleman
The challenge for conformal therapy for prostate cancer.
International journal of radiation oncology, biology, physics 1993;26(4):705-7.
1993: C Norman Coleman; I D Kaplan
Prostate cancer. Technology versus biology.
Cancer 1993;72(2):305-9.
1993: C Norman Coleman
Beneficial liaisons: radiobiology meets cellular and molecular biology.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1993;28(1):1-15.
1993: M Uematsu; Nancy J Tarbell; Barbara Silver; C Norman Coleman; D S Rosenthal; Larry N Shulman; George P Canellos; H Weinstein; Peter M Mauch
Wide-field radiation therapy with or without chemotherapy for patients with Hodgkin disease in relapse after initial combination chemotherapy.
Cancer 1993;72(1):207-12.
1993: Roy B Tishler; Stuart K Calderwood; C Norman Coleman; Brendan Price
Increases in sequence specific DNA binding by p53 following treatment with chemotherapeutic and DNA damaging agents.
Cancer research 1993;53(10 Suppl):2212-6.
1993: E A Healey; Nancy J Tarbell; L A Kalish; Barbara Silver; D S Rosenthal; Karen Marcus; Larry N Shulman; C Norman Coleman; George P Canellos; H Weinstein
Prognostic factors for patients with Hodgkin disease in first relapse.
Cancer 1993;71(8):2613-20.
1993: K T Kelsey; M Caggana-Aviles; Peter M Mauch; C Norman Coleman; Larry N Shulman; H L Liber
Mutagenesis after therapy for Hodgkin's disease.
Hematology/oncology clinics of North America 1993;7(2):353-67.
1993: Peter M Mauch; L A Kalish; M Kadin; C Norman Coleman; R Osteen; S Hellman
Patterns of presentation of Hodgkin disease. Implications for etiology and pathogenesis.
Cancer 1993;71(6):2062-71.
1993: Michael J Chusid; Peter L Havens; C Norman Coleman
Alpha omega alpha election and medical school thesis publication: relationship to subsequent publication rate over a twenty-year period.
The Yale journal of biology and medicine 1993;66(2):67-73.
1993: J L Bruce; Brendan Price; C Norman Coleman; Stuart K Calderwood
Oxidative injury rapidly activates the heat shock transcription factor but fails to increase levels of heat shock proteins.
Cancer research 1993;53(1):12-5.
1992: M Caggana; Howard Liber; C Norman Coleman; Peter M Mauch; J R Clark; K T Kelsey
A prospective study of hprt mutant and mutation frequencies in treated cancer patients.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1992;1(7):573-80.
1992: J H Meerwaldt; C Norman Coleman; R I Fischer; T A Lister; V Diehl
Role of additional radiotherapy in advanced stages of Hodgkin's disease.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1992;3 Suppl 4():83-5.
1992: S A Holden; Beverly A Teicher; G Ara; T S Herman; C Norman Coleman
Enhancement of alkylating agent activity by SR-4233 in the FSaIIC murine fibrosarcoma.
Journal of the National Cancer Institute 1992;84(3):187-93.
1992: EA Bump; R al-Sarraf; S M Pierce; C Norman Coleman
Elevation of mouse kidney thiol content following administration of glutathione.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1992;23(1):21-5.
1992: James B Mitchell; C Norman Coleman
Biochemical modification of therapeutic response.
International journal of radiation oncology, biology, physics 1992;22(3):483-4.
1992: EA Bump; C Norman Coleman; B A Cerce; D J McGinnis
Sensitization of Chinese hamster ovary cells to melphalan by etanidazole under intermittent hypoxia.
International journal of radiation oncology, biology, physics 1992;22(4):731-5.
1992: C Norman Coleman; L Noll; N Riese; L Buswell; A E Howes; Jay S Loeffler; E Alexander; Patrick Y Wen; Jay R Harris; R A Kramer
Final report of the phase I trial of continuous infusion etanidazole (SR 2508): a Radiation Therapy Oncology Group study.
International journal of radiation oncology, biology, physics 1992;22(3):577-80.
1992: S J Hurwitz; C Norman Coleman; N Riese; Jay S Loeffler; E Alexander; L Buswell; T Y Neben; L Shargel; R A Kramer
Distribution of etanidazole into human brain tumors: implications for treating high grade gliomas.
International journal of radiation oncology, biology, physics 1992;22(3):573-6.
1992: D J Lee; T L Phillips; C Norman Coleman; D Cosmatos; L W Davis; T H Wasserman; V A Marcial; Philip Rubin
Logistics in designing clinical trials for etanidazole (SR 2508): an RTOG experience.
International journal of radiation oncology, biology, physics 1992;22(3):569-71.
1992: C Norman Coleman; L Buswell; L Noll; N Riese; M A Rose
The efficacy of pharmacokinetic monitoring and dose modification of etanidazole on the incidence of neurotoxicity: results from a phase II trial of etanidazole and radiation therapy in locally advanced prostate cancer.
International journal of radiation oncology, biology, physics 1992;22(3):565-8.
1991: C Jacobs; S Kaubisch; Joanne Halsey; B L Lum; M Gosland; C Norman Coleman; Branimir I Sikic
The use of probenecid as a chemoprotector against cisplatin nephrotoxicity.
Cancer 1991;67(6):1518-24.
1991: Beverly A Teicher; T S Herman; J Tanaka; Joseph P Eder; S A Holden; G Bubley; C Norman Coleman; Emil Frei
Modulation of alkylating agents by etanidazole and Fluosol-DA/carbogen in the FSaIIC fibrosarcoma and EMT6 mammary carcinoma.
Cancer research 1991;51(4):1086-91.
1991: Beverly A Teicher; T S Herman; Larry N Shulman; G Bubley; C Norman Coleman; Emil Frei
Combination of etanidazole with cyclophosphamide and platinum complexes.
Cancer chemotherapy and pharmacology 1991;28(3):153-8.
1991: M Caggana; Howard Liber; Peter M Mauch; C Norman Coleman; K T Kelsey
In vivo somatic mutation in the lymphocytes of Hodgkin's disease patients.
Environmental and molecular mutagenesis 1991;18(1):6-13.
1990: Jay S Loeffler; E Alexander; Patrick Y Wen; W M Shea; C Norman Coleman; Hanne M Kooy; H A Fine; L A Nedzi; B Silver; N E Riese
Results of stereotactic brachytherapy used in the initial management of patients with glioblastoma.
Journal of the National Cancer Institute 1990;82(24):1918-21.
1990: T S Herman; Beverly A Teicher; C Norman Coleman
Interaction of SR-4233 with hyperthermia and radiation in the FSaIIC murine fibrosarcoma tumor system in vitro and in vivo.
Cancer research 1990;50(16):5055-9.
1990: Rebecca Gelman; Richard D Gelber; I C Henderson; C Norman Coleman; Jay R Harris
Improved methodology for analyzing local and distant recurrence.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(3):548-55.
1990: V J Picozzi; C Norman Coleman
Lymphoblastic lymphoma.
Seminars in oncology 1990;17(1):96-103.
1990: C Norman Coleman; T H Wasserman; R C Urtasun; Joanne Halsey; L Noll; S Hancock; T L Phillips
Final report of the phase I trial of the hypoxic cell radiosensitizer SR 2508 (etanidazole) Radiation Therapy Oncology Group 83-03.
International journal of radiation oncology, biology, physics 1990;18(2):389-93.
1990: C Norman Coleman; A T Turrisi
Radiation and chemotherapy sensitizers and protectors.
Critical reviews in oncology/hematology 1990;10(3):225-52.
1989: Jay S Loeffler; E Alexander; R L Siddon; W M Saunders; C Norman Coleman; Ken R Winston
Stereotactic radiosurgery for intracranial arteriovenous malformations using a standard linear accelerator.
International journal of radiation oncology, biology, physics 1989;17(3):673-7.
1989: C Norman Coleman
Modification of radiotherapy by radiosensitizers and cancer chemotherapy agents. I. Radiosensitizers.
Seminars in oncology 1989;16(3):169-75.
1989: R M Macklis; W D Kaplan; James L M Ferrara; R W Atcher; J J Hines; Steven J Burakoff; C Norman Coleman
Alpha particle radio-immunotherapy: animal models and clinical prospects.
International journal of radiation oncology, biology, physics 1989;16(6):1377-87.
1989: Mary Ann Stevenson; Stuart K Calderwood; C Norman Coleman
Effects of nitroimidazoles on neuronal cells in vitro.
International journal of radiation oncology, biology, physics 1989;16(5):1225-30.
1989: C Norman Coleman; L Noll; A E Howes; Jay R Harris; J Zakar; R A Kramer
Initial results of a phase I trial of continuous infusion SR 2508 (etanidazole): a radiation therapy oncology group study.
International journal of radiation oncology, biology, physics 1989;16(4):1085-7.
1989: G S Lederman; T S Herman; Maxine Jochelson; B J Silver; J T Chaffey; M B Garnick; J Richie; T A Sheldon; C Norman Coleman
Radiation therapy of seminoma: 17-year experience at the Joint Center for Radiation Therapy.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1989;14(3):203-8.
1989: J R Harris; C Norman Coleman
Estimating the risk of second primary tumors following cancer treatment.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(1):5-6.
1988: Peter M Mauch; Nancy J Tarbell; H Weinstein; Barbara Silver; T Goffman; R Osteen; A Zajac; C Norman Coleman; George P Canellos; D Rosenthal
Stage IA and IIA supradiaphragmatic Hodgkin's disease: prognostic factors in surgically staged patients treated with mantle and paraaortic irradiation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1988;6(10):1576-83.
1988: C Norman Coleman; R W Carlson; R A Artim; W I Sampson; H J Lawrence; P Wong; Joanne Halsey; M Kohler; M Gribble; Branimir I Sikic
Enhancement of the clinical activity of melphalan by the hypoxic cell sensitizer misonidazole.
Cancer research 1988;48(12):3528-32.
1988: A E Howes; C Norman Coleman; T L Phillips; R Sutherland
Combined modality therapy using cytotoxic agents and radiation therapy.
American journal of clinical oncology 1988;11(3):304-12.
1988: R M Macklis; B M Kinsey; Amin I Kassis; James L M Ferrara; R W Atcher; J J Hines; C Norman Coleman; S James Adelstein; Steven J Burakoff
Radioimmunotherapy with alpha-particle-emitting immunoconjugates.
Science (New York, N.Y.) 1988;240(4855):1024-6.
1988: C Norman Coleman
Hypoxia in tumors: a paradigm for the approach to biochemical and physiologic heterogeneity.
Journal of the National Cancer Institute 1988;80(5):310-7.
1988: C Norman Coleman; EA Bump; R A Kramer
Chemical modifiers of cancer treatment.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1988;6(4):709-33.
1988: T S Herman; B A Teicher; Maxine Jochelson; J Clark; G Svensson; C Norman Coleman
Rationale for use of local hyperthermia with radiation therapy and selected anticancer drugs in locally advanced human malignancies.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 1988;4(2):143-58.
1988: Margaret A Tucker; C Norman Coleman; R S Cox; A Varghese; Steven A Rosenberg
Risk of second cancers after treatment for Hodgkin's disease.
The New England journal of medicine 1988;318(2):76-81.
1988: EA Bump; S M Pierce; C H Obcemea; Lynda Chin; C Norman Coleman
Effect of OH scavenging on the yield of radiation-induced DNA double-strand breaks in isolated nuclei.
Basic life sciences 1988;49():429-32.
1987: G S Lederman; T A Sheldon; J T Chaffey; T S Herman; Rebecca Gelman; C Norman Coleman
Cardiac disease after mediastinal irradiation for seminoma.
Cancer 1987;60(4):772-6.
1987: A Tseng; C Jacobs; C Norman Coleman; S J Horning; B J Lewis; S A Rosenberg
Treatment of refractory non-Hodgkin's lymphomas of unfavorable histology with teniposide, cytarabine, and cisplatin.
Cancer treatment reports 1987;71(6):659-60.
1987: A Tseng; C Jacobs; C Norman Coleman; S J Horning; B J Lewis; S A Rosenberg
Third-line chemotherapy for resistant Hodgkin's disease with lomustine, etoposide, and methotrexate.
Cancer treatment reports 1987;71(5):475-8.
1987: J Watchie; C Norman Coleman; T A Raffin; R S Cox; A A Raubitschek; T Fahey; R T Hoppe; A Van Kessel
Minimal long-term cardiopulmonary dysfunction following treatment for Hodgkin's disease.
International journal of radiation oncology, biology, physics 1987;13(4):517-24.
1987: C Norman Coleman; Joanne Halsey; R S Cox; V K Hirst; T Blaschke; A E Howes; T H Wasserman; R C Urtasun; T Pajak; S Hancock
Relationship between the neurotoxicity of the hypoxic cell radiosensitizer SR 2508 and the pharmacokinetic profile.
Cancer research 1987;47(1):319-22.
1986: C Norman Coleman; V J Picozzi; R S Cox; K McWhirter; L M Weiss; J R Cohen; K P Yu; S A Rosenberg
Treatment of lymphoblastic lymphoma in adults.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1986;4(11):1628-37.
1986: C Norman Coleman; T H Wasserman; R C Urtasun; Joanne Halsey; V K Hirst; S Hancock; T L Phillips
Phase I trial of the hypoxic cell radiosensitizer SR-2508: the results of the five to six week drug schedule.
International journal of radiation oncology, biology, physics 1986;12(7):1105-8.
1986: J I Bernstein; C Norman Coleman; J G Strickler; R F Dorfman; S A Rosenberg
Combined modality therapy for adults with small noncleaved cell lymphoma (Burkitt's and non-Burkitt's types).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1986;4(6):847-58.
1986: C Norman Coleman
Secondary malignancy after treatment of Hodgkin's disease: an evolving picture.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1986;4(6):821-4.
1986: Mark S Kaminski; C Norman Coleman; T V Colby; R S Cox; S A Rosenberg
Factors predicting survival in adults with stage I and II large-cell lymphoma treated with primary radiation therapy.
Annals of internal medicine 1986;104(6):747-56.
1985: C Norman Coleman
Hypoxic cell radiosensitizers: expectations and progress in drug development.
International journal of radiation oncology, biology, physics 1985;11(2):323-9.
1985: M A Tucker; D Misfeldt; C Norman Coleman; W H Clark; S A Rosenberg
Cutaneous malignant melanoma after Hodgkin's disease.
Annals of internal medicine 1985;102(1):37-41.
1984: C Norman Coleman; R C Urtasun; T H Wasserman; S Hancock; J W Harris; Joanne Halsey; V K Hirst
Initial report of the phase I trial of the hypoxic cell radiosensitizer SR-2508.
International journal of radiation oncology, biology, physics 1984;10(9):1749-53.
1984: R C Urtasun; C Norman Coleman; T H Wasserman; T L Phillips
Clinical trials with hypoxic cell sensitizers: time to retrench or time to push forward?
International journal of radiation oncology, biology, physics 1984;10(9):1691-6.
1984: C Jacobs; C Norman Coleman; L Rich; K Hirst; Michael Weiner
Inhibition of cis-diamminedichloroplatinum secretion by the human kidney with probenecid.
Cancer research 1984;44(8):3632-5.
1984: C Norman Coleman; V K Hirst; D M Brown; Joanne Halsey
The effect of vitamin B6 on the neurotoxicity and pharmacology of desmethylmisonidazole and misonidazole: clinical and laboratory studies.
International journal of radiation oncology, biology, physics 1984;10(8):1381-6.
1984: A Tseng; C Norman Coleman; R S Cox; T V Colby; R R Turner; S J Horning; S A Rosenberg
The treatment of malignant histiocytosis.
Blood 1984;64(1):48-53.
1984: C Norman Coleman; S C Ballon; A E Howes; A Martinez; Joanne Halsey; V K Hirst
The current status of drug development of hypoxic cell radiosensitizers and their potential role in gynecologic oncology.
Gynecologic oncology 1984;18(1):18-27.
1984: J F Levine; C Norman Coleman; R S Cox; G R Ray; W M Rogoway; A Martinez; F E Stockdale
The effect of postoperative and primary radiation therapy on delivered dose of adjuvant cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) chemotherapy in breast cancer.
Cancer 1984;53(2):237-41.
1983: C Norman Coleman; M K Friedman; C Jacobs; Joanne Halsey; R Ignoffo; S Leibel; V K Hirst; M Gribble; S K Carter; T L Phillips
Phase I trial of intravenous L-phenylalanine mustard plus the sensitizer misonidazole.
Cancer research 1983;43(10):5022-5.
1982: C Norman Coleman
Secondary neoplasms in patients treated for cancer: etiology and perspective.
Radiation research 1982;92(1):188-200.
1982: C Norman Coleman; T H Wasserman; T L Phillips; John M Strong; R C Urtasun; J G Schwade; R J Johnson; G Zagars
Initial pharmacology and toxicology of intravenous desmethylmisonidazole.
International journal of radiation oncology, biology, physics 1982;8(3-4):371-5.
1982: R T Hoppe; C Norman Coleman; R S Cox; S A Rosenberg; H S Kaplan
The management of stage I--II Hodgkin's disease with irradiation alone or combined modality therapy: the Stanford experience.
Blood 1982;59(3):455-65.
1982: C Norman Coleman; W W Lee; L S Constine; J M Brown
The development of an oral prodrug, SR-2545, of the 2-nitroimidazole radiosensitizer SR-2508.
International journal of radiation oncology, biology, physics 1982;8(3-4):431-4.
1982: C Norman Coleman
Adverse effects of cancer therapy. Risk of secondary neoplasms.
The American journal of pediatric hematology/oncology 1982;4(1):103-11.
1982: S B Brown; M Brant-Zawadzki; P Eifel; C Norman Coleman; D R Enzmann
CT of irradiated solid tumor metastases to the brain.
Neuroradiology 1982;23(3):127-31.
1982: C Norman Coleman; I R McDougall; M O Dailey; P Ager; S Bush; H S Kaplan
Functional hyposplenia after splenic irradiation for Hodgkin's disease.
Annals of internal medicine 1982;96(1):44-7.
1981: M O Dailey; C Norman Coleman; L F Fajardo
Splenic injury caused by therapeutic irradiation.
The American journal of surgical pathology 1981;5(4):325-31.
1981: C Norman Coleman; J R Cohen; J S Burke; S A Rosenberg
Lymphoblastic lymphoma in adults: results of a pilot protocol.
Blood 1981;57(4):679-84.
1980: R A Miller; C Norman Coleman; H D Fawcett; R T Hoppe; I R McDougall
Sézary syndrome: a model for migration of T lymphocytes to skin.
The New England journal of medicine 1980;303(2):89-92.
1980: I R McDougall; C Norman Coleman; J S Burke; W Saunders; H S Kaplan
Thyroid carcinoma after high-dose external radiotherapy for Hodgkin's disease: report of three cases.
Cancer 1980;45(8):2056-60.
1980: M O Dailey; C Norman Coleman; H S Kaplan
Radiation-induced splenic atrophy in patients with Hodgkin's disease and non-Hodgkin's lymphomas.
The New England journal of medicine 1980;302(4):215-7.
1977: C Norman Coleman; C J Williams; Andrew Flint; E J Glatstein; S A Rosenberg; H S Kaplan
Hematologic neoplasia in patients treated for Hodgkin's disease.
The New England journal of medicine 1977;297(23):1249-52.
1975: C Norman Coleman; R G Stoller; J C Drake; B A Chabner
Deoxycytidine kinase: properties of the enzyme from human leukemic granulocytes.
Blood 1975;46(5):791-803.
1975: R G Stoller; C Norman Coleman; P Chang; K R Hande; B A Chabner
Biochemical pharmacology of cytidine analog metabolism in human leukemic cells.
Bibliotheca haematologica 1975;(43):531-3.
1975: C Norman Coleman; D G Johns; B A Chabner
Studies on mechanisms of resistance to cytosine arabinoside: problems in the determination of related enzyme activities in leukemic cells.
Annals of the New York Academy of Sciences 1975;255():247-51.
1975: B A Chabner; C E Myers; C Norman Coleman; D G Johns
The clinical pharmacology of antineoplastic agents (second of two parts).
The New England journal of medicine 1975;292(22):1159-68.
1975: B A Chabner; C E Myers; C Norman Coleman; D G Johns
The clinical pharmacology of antineoplastic agents (first of two parts).
The New England journal of medicine 1975;292(21):1107-13.
1974: B A Chabner; D G Johns; C Norman Coleman; J C Drake; W H Evans
Purification and properties of cytidine deaminase from normal and leukemic granulocytes.
The Journal of clinical investigation 1974;53(3):922-31.
1973: R F Lange; N R Shulman; P A Tomasulo; C Norman Coleman
Metabolic effects of antibodies on platelets.
Transactions of the Association of American Physicians 1973;86():131-42.